China begins clinical trials on Stem Cells to help leukemia and other patients suffering from severe diseases. An injection of primitive mesenchymal stem cells developed by Chinese scientists. Pre-clinical trials for treating coronary disease, diabetes, liver failure and other severe cases.
Focusing on repairing damaged or malfunctioning tissue organs, is expected to greatly upgrade the efficiency in treating such serious cases. The human body is something like a "cell world" consisting of 1,000,000 billion cells in more than 200 kinds of different tissues. Those cells derive from stem cells with high potential in reproductive fission. Zhao's research team has isolated potent stem cells from bone marrow, that can be induced and then fuse into various tissue cells in a given body environment, so as to help patients repair and renew organisms. Zhao said the first phase of clinical experiments will conclude in three months.
No comments:
Post a Comment